Accessibility Menu
Takeda Pharmaceutical logo

Takeda Pharmaceutical

(OTC) TKPHF

Current Price$30.47
Market Cap$50.71B
Since IPO (2003)-7%
5 Year+12%
1 Year+21%
1 Month-8%

Takeda Pharmaceutical Financials at a Glance

Market Cap

$50.71B

Revenue (TTM)

¥4.51T

Net Income (TTM)

¥191.70B

EPS (TTM)

$0.81

P/E Ratio

38.90

Dividend

$1.30

Beta (Volatility)

0.07 (Low)

Price

$30.47

Volume

1,190

Open

$30.47

Previous Close

$30.47

Daily Range

$30.47 - $30.47

52-Week Range

$26.30 - $39.20

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Takeda Pharmaceutical

Industry

Pharmaceuticals

Employees

47,455

CEO

Christophe Weber, PhD

Headquarters

Tokyo, 103-8668, JP

TKPHF Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

11%

Net Income Margin

4%

Return on Equity

3%

Return on Capital

4%

Return on Assets

1%

Earnings Yield

2.57%

Dividend Yield

4.06%

Payout Ratio

1.63%

Stock Overview

Market Cap

$50.71B

Shares Outstanding

1.58B

Volume

1.19K

Avg. Volume

34.68K

Financials (TTM)

Gross Profit

¥2.32T

Operating Income

¥543.85B

EBITDA

¥1.27T

Operating Cash Flow

¥944.62B

Capital Expenditure

-¥177.11B

Free Cash Flow

¥767.51B

Cash & ST Invst.

¥598.80B

Total Debt

¥4.91T

Takeda Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

¥1.10T

+4.6%

Gross Profit

¥537.36B

-20.0%

Gross Margin

48.79%

N/A

Market Cap

$50.71B

N/A

Market Cap/Employee

$1.03M

N/A

Employees

49,281

N/A

Net Income

-¥24.47B

+76.3%

EBITDA

¥211.88B

+188.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

-¥4.31T

-5.0%

Accounts Receivable

¥881.86B

+21.6%

Inventory

¥1.41T

+15.4%

Long Term Debt

¥4.40T

+10.9%

Short Term Debt

¥515.38B

-6.1%

Return on Assets

1.24%

N/A

Return on Invested Capital

3.65%

N/A

Free Cash Flow

-¥6.03B

-104.7%

Operating Cash Flow

¥40.62B

-81.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HOCPFHOYA Corporation
$166.17+1.98%
LZAGYLonza Group AG
$63.99-0.19%
WUXAYWuXi AppTec Co., Ltd.
$15.74-1.25%
IPSEYIpsen S.A.
$44.92-3.61%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$114.68-0.05%
SPCEVirgin Galactic
$6.18+0.36%
SOFISoFi Technologies
$18.22+0.07%
ONDSOndas
$13.22-0.00%

Questions About TKPHF

What is the current price of Takeda Pharmaceutical?

Takeda Pharmaceutical is trading at $30.47 per share.

What is the 52-week range for Takeda Pharmaceutical?

Over the past 52 weeks, Takeda Pharmaceutical has traded between $26.30 and $39.20.

How much debt does Takeda Pharmaceutical have?

As of the most recent reporting period, Takeda Pharmaceutical reported total debt of ¥30.69B.

How much cash does Takeda Pharmaceutical have on hand?

Takeda Pharmaceutical reported ¥3.74B in cash and cash equivalents in its most recent financial results.

What is Takeda Pharmaceutical’s dividend yield?

Takeda Pharmaceutical currently has a dividend yield of 4.06%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.